Literature DB >> 7453089

Hematin therapy in porphyric attacks.

C A Pierach, I Bossenmaier, R Cardinal, M Weimer, C J Watson.   

Abstract

We report our experience with hematin in the treatment of 57 patients in porphyric attacks. The ratio of acute intermittent porphyria: variegate porphyria: hereditary coproporphyria was 43:11:3. More than 90% of the patients showed not only a decline in their porphyrin precursors, but also a favor able clinical response. Hematin was well tolerated and should be considered the treatment of choice in porphyric relapse.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7453089     DOI： 10.1007/bf01491103

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  16 in total

1.  Effects of hematin in hepatic porphyria. Further studies.

Authors:  G J Dhar; I Bossenmaier; Z J Petryka; R Cardinal; C J Watson
Journal:  Ann Intern Med       Date:  1975-07       Impact factor: 25.391

Review 2.  [Hematin in the treatment of acute hepatic porphyrias].

Authors:  W Thier
Journal:  Internist (Berl)       Date:  1979-09       Impact factor: 0.743

3.  [Effect of hematin in acute porphyric relapse].

Authors:  V Monsalve; C Wolff; R Gómez; R Armas Merino; C Canals
Journal:  Rev Med Chil       Date:  1979-01       Impact factor: 0.553

4.  Incorporation of exogenous heme into hepatic cytochrome P-450 in vivo.

Authors:  M A Correia; G C Farrell; R Schmid; P R Ortiz de Montellano; G S Yost; B A Mico
Journal:  J Biol Chem       Date:  1979-01-10       Impact factor: 5.157

5.  [Hematin treatment of acute intermittent porphyria. A case report (author's transl)].

Authors:  P E Marchiori; J L de Assis; M Scaff; L G Do Serro-Azul; E C Moraes; L A Bacheschi; N Yassuda
Journal:  Rev Bras Pesqui Med Biol       Date:  1979-09

6.  Hematin therapy for acute porphyria.

Authors:  J M Lamon; B C Frykholm; R A Hess; D P Tschudy
Journal:  Medicine (Baltimore)       Date:  1979-05       Impact factor: 1.889

7.  Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission.

Authors:  G J Dhar; I Bossenmaier; R Cardinal; Z J Petryka; C J Watson
Journal:  Acta Med Scand       Date:  1978

8.  Hematin administration to an adult with lead intoxication.

Authors:  J M Lamon; B C Frykholm; D P Tschudy
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

9.  Hematin and propranolol in acute intermittent porphyria. Full recovery from quadriplegic coma and respiratory failure.

Authors:  M Brezis; J Ghanem; D Weiler-Ravell; O Epstein; D Morris
Journal:  Eur Neurol       Date:  1979       Impact factor: 1.710

10.  Postulated deficiency of hepatic heme and repair by hematin infusions in the "inducible" hepatic porphyrias.

Authors:  C J Watson; C A Pierach; I Bossenmaier; R Cardinal
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205
View more
  4 in total

1.  Pharmacokinetics of intravenously administered haem arginate.

Authors:  O Tokola; R Tenhunen; L Volin; P Mustajoki
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

2.  The "glucose effect" in acute hepatic porphyrias and in experimental porphyria.

Authors:  M Doss; F Verspohl
Journal:  Klin Wochenschr       Date:  1981-07-01

3.  Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation.

Authors:  G S Drummond; A Kappas
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

Review 4.  Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know.

Authors:  Petro E Petrides
Journal:  Diagnostics (Basel)       Date:  2022-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.